survival

Open Access
Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis
FAUSTO PETRELLI, CARMEN REA, MARIA CHIARA PARATI, KAREN BORGONOVO, MARA GHILARDI, LORENZO DOTTORINI, ANDREA LUCIANI, MICHELE GHIDINI, FIORELLA RUATTA, ORNELLA GARRONE and GIANLUCA TOMASELLO

Anticancer Research October 2023, 43 (10) 4303-4313; DOI: https://doi.org/10.21873/anticanres.16625
Open Access
Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study
MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS and IRMINA MARIA MICHALEK

Anticancer Research October 2023, 43 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.16645
You have access
Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases
MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS, ALDONA MATUSZCZYK, EDYTA DEREZINSKA-WOLEK and IRMINA MARIA MICHALEK

Anticancer Research October 2023, 43 (10) 4551-4557; DOI: https://doi.org/10.21873/anticanres.16649
Open Access
GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy
TRISTAN M. SISSUNG, SARAH LOCHRIN, TYLER LIU, KEITH SCHMIDT, JONATHAN STROPE, EMILY RISDON, HYOYOUNG CHOO-WOSOBA, DAVID J. VENZON, WIEM LASSOUED, HOUSSEIN A. SATER, BEATRIZ WALTER-RODRIGUEZ, DOUGLAS K. PRICE and WILLIAM D. FIGG

Anticancer Research September 2023, 43 (9) 4023-4030; DOI: https://doi.org/10.21873/anticanres.16590
You have access
Melanoma of the Lower Limbs and Hips: A Surveillance, Epidemiology, and End Results Analysis of Epidemiology and Survival 2000-2019
SOLANGE N. WALZ, JÉRÔME MARTINEAU, MATTEO SCAMPA, SRINIVAS MADDURI, DANIEL F. KALBERMATTEN and CARLO M. ORANGES

Anticancer Research September 2023, 43 (9) 4105-4113; DOI: https://doi.org/10.21873/anticanres.16600
You have access
ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies
YI MING YANG, FIONA RUGE, KE JI, SHUQIN JIA, YONGNING JIA, ANDREW J. SANDERS, JIAFU JI and WEN G. JIANG

Anticancer Research April 2023, 43 (4) 1463-1475; DOI: https://doi.org/10.21873/anticanres.16295
You have access
Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma
JEN-YU CHENG, BING-SHEN HUANG, YEN-YANG CHEN, CHIH-CHI WANG and YEN-HAO CHEN

Anticancer Research March 2023, 43 (3) 1361-1371; DOI: https://doi.org/10.21873/anticanres.16284
You have access
Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck
INGA ZWAAN, TAMER SOROR, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES

Anticancer Research February 2023, 43 (2) 795-800; DOI: https://doi.org/10.21873/anticanres.16220
You have access
Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma
FLORIAN WEBER, RUDOLF JUNG, OLIVER TREECK and CHRISTA BUECHLER

Anticancer Research February 2023, 43 (2) 831-839; DOI: https://doi.org/10.21873/anticanres.16225
You have access
Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, NAO KITASAKI and MORIHITO OKADA

Anticancer Research December 2022, 42 (12) 6037-6045; DOI: https://doi.org/10.21873/anticanres.16115

Main menu

User menu

Search

survival

Pages